Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9PX7

ATTR cardiac amyloid fibrils apex2

Summary for 9PX7
Entry DOI10.2210/pdb9px7/pdb
EMDB information71960
DescriptorTransthyretin (1 entity in total)
Functional Keywordstransthyretin, amyloidosis, protein fibril
Biological sourceHomo sapiens (human)
Total number of polymer chains6
Total formula weight95429.90
Authors
Schaefer, J.H.,Lander, G.C. (deposition date: 2025-08-05, release date: 2026-05-13)
Primary citationDonnelly, J.P.,Schafer, J.H.,Yoon, L.,Massey, L.A.,Ash, C.,Gao, Z.,Nugroho, K.,Jager, M.,Pang, Z.,O'Neill, R.T.,Maurer, M.S.,Powers, E.T.,Lander, G.C.,Ye, L.,Kelly, J.W.
Three-Dimensional Visualization and Proteomic Analysis of Human Cardiac Transthyretin Amyloidosis Tissue Reveals Microangiopathy and Capillary Occlusion.
J Am Heart Assoc, :e042248-e042248, 2026
Cited by
PubMed Abstract: Transthyretin amyloidosis (ATTR) is a degenerative disease affecting the heart and other organs. Transthyretin (TTR) aggregation is a driver of ATTR pathology, but the mechanism is poorly understood. We used proteomics and tissue clearing technology on wild-type (WT) human cardiac (WT/WT) and V122I human cardiac (V122I/WT) tissue to better understand TTR cardiomyopathy.
PubMed: 42089154
DOI: 10.1161/JAHA.125.042248
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.4 Å)
Structure validation

253389

PDB entries from 2026-05-13

PDB statisticsPDBj update infoContact PDBjnumon